March 10, 2017 – On March 8, 2017, a jury ruled in favor of Plaintiffs W.L. Gore & Associates Inc. et al. against Defendants C.R. Bard Inc. et al. in the United States District Court for the District of Delaware. The patents-at-issue were U.S. Patent Nos. 5,700,285, 5,735,892, and 8,221,487, with claims directed towards intraluminal stent grafts. The asserted claims were found to be not invalid and not infringed.
The case is captioned, W.L. Gore & Associates Inc. et al. v. C.R. Bard Inc. et al., 1-11-cv-00515.
By: Madhundra Sivakumar